New Delhi, September 3 (HS): Anlon Healthcare, a manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), made a flat debut on the stock market today, dampening investor sentiment despite strong demand during its IPO.

Shares of the company were issued at ₹91 per share. On debut, the stock listed flat at ₹91 on the BSE, while on the NSE it opened with a marginal 1% premium at ₹92. Post-listing, the stock continued to trade within a narrow range. By 11:30 a.m., Anlon Healthcare shares were hovering around ₹91.80.

The company’s ₹121 crore IPO, which was open from August 26 to 29, had garnered strong investor response and was oversubscribed seven times overall. The price band for the issue was fixed at ₹86–91 per share.

Funds raised through the IPO will be deployed towards expansion of manufacturing facilities, repayment of existing debt, working capital requirements, and other general corporate purposes, the company stated.

—————

Hindusthan Samachar / Jun Sarkar